Select Page

RevMAb Biosciences adds 23 New IHC-Validated Rabbit mAb to their Portfolio

RevMAb logo

23 New IHC-Validated Rabbit mAb from RevMab Biosciences

RevMAb Biosciences has just released 23 IHC-Validated Rabbit mAbs. These new antibodies target proteins such as Beta-Catenin, Smad4, mTor, EGFR, Stat3, PTEN, Paxillin and many others. Out of the lot, RevMAb Biosciences released a new Histone H3.3 mutant antibody, namely Anti-H3.3 G34W Mutant rabbit monoclonal antibody [RM263]. This antibody complements the already released Anti-Histone H3.3 G34R Mutant rabbit monoclonal antibody [RM240].

All their latest RevMAb Rabbit mAb have been validated for IHC detection.

 

About RevMAb Biosciences

RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation.